3 776

Cited 0 times in

크론병 환자에서 Infliximab 치료 후 발생한 중증 다발성 결핵 1예

DC Field Value Language
dc.contributor.author김번-
dc.contributor.author박효진-
dc.contributor.author변민광-
dc.contributor.author윤영훈-
dc.contributor.author이상인-
dc.contributor.author장성일-
dc.date.accessioned2014-12-19T17:52:59Z-
dc.date.available2014-12-19T17:52:59Z-
dc.date.issued2012-
dc.identifier.issn1226-329X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/92236-
dc.description.abstractInfliximab, a tumor necrosis factor-alpha (TNF-alpha) inhibitor, has been approved for the treatment of a variety of inflammatory illnesses, including Crohn's disease. However, infliximab can increase the risk of reactivation of latent tuberculosis (Tbc) infection by affecting host immune responses. Therefore, a screening test should be performed before the initiation of infliximab therapy, and patients with evidence of latent infection should be treated with prophylactic anti-Tbc therapy. Here, we report a case of multifocal disseminated tuberculosis after treatment with infliximab in a patient diagnosed with Crohn's disease who had no past history of Tbc and showed a negative screening test.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfKorean Journal of Medicine-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title크론병 환자에서 Infliximab 치료 후 발생한 중증 다발성 결핵 1예-
dc.title.alternativeA Case of Multiple Tuberculosis Associated with Infliximab Therapy in Crohn's Disease.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthor김희욱-
dc.contributor.googleauthor장성일-
dc.contributor.googleauthor김번-
dc.contributor.googleauthor윤영훈-
dc.contributor.googleauthor변민광-
dc.contributor.googleauthor박효진-
dc.contributor.googleauthor이상인-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00486-
dc.contributor.localIdA01774-
dc.contributor.localIdA01848-
dc.contributor.localIdA02583-
dc.contributor.localIdA02828-
dc.contributor.localIdA03441-
dc.relation.journalcodeJ02059-
dc.identifier.pmidEosinophilic cholecystitis ; Idiopathic ; Steroids-
dc.identifier.urlhttp://www.ekjm.org/journal/view.php?number=23029-
dc.subject.keywordEosinophilic cholecystitis-
dc.subject.keywordIdiopathic-
dc.subject.keywordSteroids-
dc.contributor.alternativeNameKim, Bun-
dc.contributor.alternativeNamePark, Hyo Jin-
dc.contributor.alternativeNameByun, Min Kwang-
dc.contributor.alternativeNameYoun, Young Hoon-
dc.contributor.alternativeNameLee, Sang In-
dc.contributor.alternativeNameJang, Sung Ill-
dc.contributor.affiliatedAuthorKim, Bun-
dc.contributor.affiliatedAuthorPark, Hyo Jin-
dc.contributor.affiliatedAuthorByun, Min Kwang-
dc.contributor.affiliatedAuthorYoun, Young Hoon-
dc.contributor.affiliatedAuthorLee, Sang In-
dc.contributor.affiliatedAuthorJang, Sung Ill-
dc.citation.volume83-
dc.citation.number3-
dc.citation.startPage337-
dc.citation.endPage341-
dc.identifier.bibliographicCitationKorean Journal of Medicine, Vol.83(3) : 337-341, 2012-
dc.identifier.rimsid29708-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.